Science Structure Therapeutics Launches Phase 1 Study for Obesity Drug Structure Therapeutics Inc. has announced the initiation of a Phase 1 clinical study for its lead drug candidate, ACCG-2671, designed to treat obesity. This... Editorial1 day ago